Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Oct 16, 2023 5:11am
Weight loss drugs
If novo nordisk , & Eli Lilly & other weight loss drugs prove safe & healthy long term, do these companies have a network in South America ? Do u think our South American distro network
...more
(1923)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Oct 14, 2023 1:54pm
5i Research
Review of Knight Therapeutics Sep 21, 2023 The share price of GUD has declined over the years, while its fundamentals have been mixed. The company maintains a very strong balance sheet and has
...more
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(1)
•••
Stockoman1
X
View Profile
View Bullboard History
Comment by
Stockoman1
on Oct 14, 2023 6:20am
RE:RE:57.08 % shares held In tight hands- sharecount shrinks
Longrun said " I am looking forward to meaningful updates from Management over the coming quarters about profitability! " AMEN !
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Oct 13, 2023 9:44am
Larry fink bullish on healthcare and living longer
Discussing great opportunities in Health care innovation and growth opportunities in Mexico , amongst others - & Great for companies in this area - on CNBC
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 10, 2023 4:45pm
New Press Release - Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil
MONTREAL, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization application for pemigatinib to ANVISA...
read article.
(155)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Oct 08, 2023 11:15am
RE:57.08 % shares held In tight hands- sharecount shrinks
It's always nicer to be in business with "owners" of the company compared to fair-weather "renters". Ultimately though, the return profile based on the capital invested is too
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Oct 06, 2023 7:54pm
57.08 % shares held In tight hands- sharecount shrinks
14.24 held by institutions 42.84% held by insiders 57.08 % shares held also, unsure if these numbers include the buybacks/cancellations, which would just increase their
...more
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Post by
gudisgood
on Oct 06, 2023 3:49am
Heavy Buybacks
1.37 million shares (around $6 million) cancelled in September. That's something like 1.3% of the company bought back in one month.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 02, 2023 4:30pm
New Press Release - Knight Therapeutics Inc. places No. 90 on The Globe and Mail's fifth-annual ranking of Canada's Top Growing Companies
MONTREAL, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it placed No. 90 on the 2023 Report on Business ranking of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies on three-year...
read article.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Oct 01, 2023 12:21pm
Article
https://www.lapresse.ca/affaires/entreprises/2022-06-15/apres-le-pactole-le-pari.php Great read - nice to have George Armoyan on the team. Lots of respect for the Board and what is being
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Sep 30, 2023 5:56pm
RE:RE:RE:Goodman and Armoyan Buying
I think there is a commment from Armoyan when he started accumulating. I think he's been given the low-down on how this company develops over time and he gets it. That's the kind of investor
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Sep 28, 2023 2:50pm
42.84%
Insider ownership. Pretty strong! I don't think that number on marketwatch includes any recent purchased discussed recently. at that strong an ownership, impressive when insiders are
...more
(155)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Sep 27, 2023 1:00pm
RE:RE:Goodman and Armoyan Buying
I think Armoyan is probably thinking the same things we are. There is a lot of capital to deploy in the future There are challenges with operating margins that need to be addressed
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Sep 27, 2023 12:22pm
RE:Goodman and Armoyan Buying
It's nice to finally see Goodman buy more in the open market. It will be interesting to see how Armoyan's partnership will unfold with Knight. He originally mentioned he will be passive
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario